Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1Phase 1 1

Status

Not yet recruiting 2Recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 100Other hematologic neoplasm 72Plasma cell 52Sarcoma 39Myeloid 31Dermatologic 18Classical hematology 16CNS 9Gynecologic 7Genitourinary 6Breast 6Other neoplasm 4Thoracic 3Head & Neck 3

Conditions

Head and Neck Neoplasms 21Squamous Cell Carcinoma of Head and Neck 18Melanoma 10Uterine Cervical Neoplasms 9Anus Neoplasms 8Neoplasm Metastasis 7Carcinoma, Non-Small-Cell Lung 7Ovarian Neoplasms 6Nasopharyngeal Carcinoma 6Vaginal Neoplasms 5Thyroid Neoplasms 5Stomach Neoplasms 5Penile Neoplasms 5Oropharyngeal Neoplasms 5Neoplasms 5Carcinoma, Renal Cell 5Breast Neoplasms 5Pancreatic Neoplasms 4Esophageal Neoplasms 4Carcinoma, Transitional Cell 4Carcinoma, Squamous Cell 4Carcinoma, Merkel Cell 4Carcinoma, Hepatocellular 4Vulvar Neoplasms 3Triple Negative Breast Neoplasms 3Small Cell Lung Carcinoma 3Sarcoma 3Recurrence 3Mouth Neoplasms 3Lung Neoplasms 3

Interventions

Cetuximab 14Cisplatin 12pembrolizumab 11Paclitaxel 9Gemcitabine 9durvalumab 6Nivolumab 6Docetaxel 6toripalimab 5Carboplatin 5Radiotherapy 4Fluorouracil 4Valproic Acid 3Cyclophosphamide 3Capecitabine 3tremelimumab 2spartalizumab 2nimotuzumab 2irinotecan sucrosofate 2fludarabine phosphate 2fludarabine 2cemiplimab 2anlotinib 2Sunitinib 2S 1 (combination) 2Radiation 2Oxaliplatin 2NVP-BKM120 2Methotrexate 2Ipilimumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recurrence × Cyclophosphamide × Head & Neck × Clear all
NCT07361133 2026-04-16

Cyclophosphamide and Etoposide as a Metronomic Therapy in Advanced Head and Neck Squamous Cell Cancer

National Cancer Institute, Egypt

Phase 2 Not yet recruiting
120 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasm Metastasis, Recurrence

NCT06096038 2026-02-20

Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC

UNC Lineberger Comprehensive Cancer Center

Phase 1/2 Recruiting
33 enrolled
Head & Neck

Head and Neck Neoplasms, Neoplasms, Recurrence

NCT05582590 2024-01-16

Autologous T Cells Targeting HPV16 HPV18 & Survivin in Patients With R/R HPV-related Oropharyngeal Cancers

NexImmune Inc.

Phase 1 Not yet recruiting
36 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasm Metastasis, Oropharyngeal Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡